Financials data is unavailable for this security.
View more
Year on year WAVE Life Sciences Ltd grew revenues 3,005.10% from 3.65m to 113.31m while net income improved from a loss of 161.82m to a smaller loss of 57.51m.
| Gross margin | -- |
|---|---|
| Net profit margin | -66.50% |
| Operating margin | -75.74% |
| Return on assets | -33.49% |
|---|---|
| Return on equity | -- |
| Return on investment | -117.16% |
More ▼
Cash flow in USDView more
In 2023, WAVE Life Sciences Ltd increased its cash reserves by 121.42%, or 111.89m. Cash Flow from Financing totalled 132.53m or 116.97% of revenues. In addition the company used 19.43m for operations while cash used for investing totalled 1.12m.
| Cash flow per share | -0.5805 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.0359 |
|---|---|
| Tangible book value per share | 0.0359 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.9939 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
